|
Market Closed -
Nasdaq
01:30:00 14/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 10.90 USD | -0.73% |
|
+1.40% | +77.24% |
| 10/07 | Immucell Corporation Reports Preliminary Unaudited Sales Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 15/05 | ImmuCell Corporation, Q1 2026 Earnings Call, May 15, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMUCELL CORPORATION | Other Pharmaceuticals | -0.73% | +1.40% | +77.24% | +63.91% | +16.76% | 9.93Cr |  |  | |
- Stock Market
- Stocks
- ICCC Stock
- Charts ImmuCell Corporation
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
